Translational Research Cancer Cente is a Public Charity headquartered in Pittsburgh, PA. Financial data from the 2024 filing: $240K revenue, $122K expenses, $214K total assets. 1 publicly reported grants to this organization, totaling roughly $8K, appear in IRS filings.
Dissemination of information regarding the prevention, treatment, and cure of cancer, integrating cancer biology and tumor immunology. Promoting research, clinical collaborations, enhanced partnerships with industry, and training of the next generation of scientists.
Showing up to 5 of 1 total records — full history available with membership.
Officer compensation and complete director data available with membership.
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $240K | $122K | $214K |
| 2023 | $115K | $124K | $92K |
| 2022 | $95K | $60K | $101K |
Between 2022 and 2024, reported annual revenue grew from $95K to $240K (+152%), with total assets most recently reported at $214K.
Interactive year-over-year charts and full filing details available with membership.
